PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Zaleplon and Carbamazepine Interaction

Drug interaction information between Zaleplon and Carbamazepine.

Zaleplon and Carbamazepine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Zaleplon and Carbamazepine. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Zaleplon

Non-Benzodiazepine Hypnotic (Z-Drug)

Drug B

Carbamazepine

Anticonvulsant

How They Interact

Carbamazepine makes your body get rid of zaleplon faster, which might make the sleep medicine stop working as well.

What To Do

Your doctor might recommend a different sleep aid that does not interact with this medication.

FDA Label Information

An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital.

Frequently Asked Questions

Can I take Zaleplon and Carbamazepine together?

This is a minor interaction. Your doctor might recommend a different sleep aid that does not interact with this medication.

How serious is the interaction between Zaleplon and Carbamazepine?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Zaleplon and Carbamazepine interact?

Carbamazepine makes your body get rid of zaleplon faster, which might make the sleep medicine stop working as well.

Understanding the Zaleplon and Carbamazepine Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Zaleplon belongs to the Non-Benzodiazepine Hypnotic (Z-Drug) class and Carbamazepine belongs to the Anticonvulsant class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Carbamazepine makes your body get rid of zaleplon faster, which might make the sleep medicine stop working as well. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Zaleplon has 16 total documented interactions on file in this dataset, and Carbamazepine has 129. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor might recommend a different sleep aid that does not interact with this medication. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Zaleplon or Carbamazepine based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.